TELZATAN CM25

TELZATAN CM25 Tablets combine Telmisartan 40 mg, an angiotensin II receptor blocker (ARB), Cilnidipine 10 mg, a calcium channel blocker, and Metoprolol Succinate 25 mg, a beta-blocker, to provide comprehensive management of hypertension (high blood pressure). This triple-action formulation helps lower blood pressure through complementary mechanisms, improving cardiovascular protection and reducing the risk of hypertension-related complications.

TELZATAN CM25 is recommended for patients whose blood pressure is not adequately controlled with single or dual therapy. It helps maintain stable blood pressure, reduces the workload on the heart, and supports long-term cardiovascular health.

Key Benefits

• Effectively controls high blood pressure
• Provides triple-action blood pressure management
• Helps reduce the risk of heart attack, stroke, and kidney damage
• Improves blood circulation by relaxing blood vessels
• Reduces the heart's workload and heart rate
• Supports long-term cardiovascular protection